InMed Pharmaceuticals Inc
NASDAQ:INM
InMed Pharmaceuticals Inc
NASDAQ:INM
Price:
0.8801
USD
-5.15%
Market Cap:
$2.5m
Balance Sheet
Balance Sheet Decomposition
InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc
Balance Sheet
InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc
Currency: USD
| Jul-2002 | Jul-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
18
|
10
|
6
|
7
|
6
|
9
|
7
|
11
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
18
|
10
|
6
|
7
|
6
|
9
|
7
|
11
|
|
| Short-Term Investments |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
20
|
14
|
6
|
8
|
10
|
11
|
9
|
13
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
4
|
4
|
5
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
-15%
|
1
-53%
|
1
+81%
|
1
-34%
|
0
-38%
|
1
+245%
|
0
-98%
|
0
+367%
|
0
+79%
|
0
-80%
|
0
-80%
|
2
+15 800%
|
1
-16%
|
1
-4%
|
6
+402%
|
21
+232%
|
15
-29%
|
8
-48%
|
10
+25%
|
13
+31%
|
14
+10%
|
12
-16%
|
16
+32%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+1 214%
|
1
-15%
|
2
+113%
|
1
-32%
|
1
+19%
|
2
+12%
|
1
-30%
|
1
+21%
|
0
-96%
|
0
-20%
|
0
+25%
|
0
+40%
|
0
-14%
|
0
+667%
|
0
-37%
|
1
+145%
|
1
+68%
|
2
+61%
|
2
+25%
|
4
+55%
|
2
-46%
|
3
+30%
|
2
-18%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
11
|
12
|
14
|
17
|
20
|
22
|
25
|
22
|
24
|
28
|
27
|
26
|
28
|
25
|
25
|
33
|
52
|
52
|
53
|
61
|
71
|
78
|
83
|
91
|
|
| Retained Earnings |
11
|
13
|
16
|
20
|
23
|
26
|
28
|
25
|
28
|
31
|
30
|
29
|
30
|
29
|
30
|
33
|
39
|
49
|
65
|
75
|
93
|
101
|
109
|
117
|
|
| Additional Paid In Capital |
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
5
|
6
|
8
|
11
|
18
|
22
|
32
|
36
|
35
|
39
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
0
-81%
|
0
N/A
|
1
-179%
|
0
+28%
|
1
-98%
|
0
+85%
|
1
-636%
|
1
-10%
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
1
-16%
|
1
-35%
|
6
+650%
|
21
+236%
|
14
-33%
|
6
-58%
|
7
+26%
|
9
+23%
|
12
+33%
|
9
-24%
|
13
+46%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
-15%
|
1
-53%
|
1
+83%
|
1
-34%
|
0
-38%
|
1
+245%
|
0
-99%
|
0
+600%
|
0
+79%
|
0
-80%
|
0
-80%
|
2
+15 800%
|
1
-16%
|
1
-4%
|
6
+402%
|
21
+232%
|
15
-29%
|
8
-48%
|
10
+25%
|
13
+31%
|
14
+10%
|
12
-16%
|
16
+32%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
0
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
